LOCKPORT, NY – VanDeMark Chemical Inc., Lockport, NY, has appointed David Rodems Chief Financial Officer (CFO). As a key member of the leadership team, he will strengthen the financial and IT infrastructure, oversee capital structure, and develop economic strategies driving profitable growth and increased shareholder value. VanDeMark is a leading North American manufacturer of phosgene and phosgene derivatives and recently acquired Framochem, a European-based manufacturer of phosgene products, as a wholly owned subsidiary.
“Dave has more than 20 years of experience as a CFO in senior financial roles on an international scale,” said Michael Kucharski, President and Chief Executive Officer of VanDeMark. “His experience in global growth initiatives will be vital to VanDeMark as the company continues to expand in the worldwide marketplace.”